Miguel Sánchez, physiotherapist, shares his experience with NESA highlighting from the first moment the economic profitability of the device, considering that the investment should not even be questioned — it always means an improvement in service quality and patient health.
His motivation to bet on NESA was clear: cover pathologies that with his previous tools fell short and offer better results in cases where he was not reaching.
His star clinical case is a woman with 7-8 years of fibromyalgia evolution, very medicated and with poor quality of life despite pharmacological treatment. In 8-10 sessions she began to notice significant changes and reduce medication. After 14-15 sessions she is completely without medication in her daily life, with a notably better quality of life and performing tasks that were previously impossible for her. Both the patient and the team recognize the result as an extraordinary success.